Valproic acid Completed Phase 3 Trials for Post-Traumatic Seizure Disorder / Injuries, Craniocerebral Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00004817Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures